Featured News

There is overwhelming scientific evidence that poor nutrition contributes to dozens of diseases, including many cancers, diabetes, heart disease, and obesity. Everyone, including government and the food industry, has a role to play in changing this fact.

The need for action is clear. The failure to understand and treat celiac disease appropriately manifests in low rates of diagnosis, lack of research funding and alternative treatments, and limited understanding of the economic and social costs of this disease. 

As a result of our work, we are pleased to announce that the Celiac Disease Foundation will host an Ask-the-FDA Educational Webinar on October 13, 2022.

Accelerating research for treatments and a cure for celiac disease is the top priority of the Celiac Disease Foundation.  We are optimistic that the current surge of research will produce…

With the 9 Meters decision to halt the CedLara Phase 3 trial because of the cost of patient recruitment, it is more imperative than ever that our celiac community comes together to…

The Celiac Disease Foundation is pleased to announce the establishment of two international celiac disease research prizes to inspire a new generation of researchers whose work in celiac disease will be invaluable.

The Celiac Disease Foundation is in discussion with a team at the University of Colorado, Denver to develop the first-ever, FDA-approved pediatric PRO (patient-reported outcome tool).

On April 8 and April 9, the Celiac Disease Foundation is sponsoring the Columbia University Celiac Disease Center International Symposium on Celiac Disease.

To share with you some insight into our advocacy work, I recently interviewed Mark Van de Water, Senior Advisor at Baker Donelson.

A few highlights from research studies published in peer-reviewed journals in the last few months are products of the research grants CDF awarded.